ログイン

Introduction

Introduction
58問 • 1年前
  • Jef Marc Valencia
  • 通報

    問題一覧

  • 1

    The study of the molecules, cells, organs, and systems responsible for the recognition and disposal of foreign (nonself) materials

    IMMUNOLOGY

  • 2

    Considered as foreign substances a.k.a Antigens

    NONSELF

  • 3

    The body can’t discriminate self from non-self.

    AUTOIMMUNE DISEASE

  • 4

    Diagnostic examination of blood serum and other body fluids with regards to the response of the immune system to pathogens.

    SEROLOGY

  • 5

    Condition of being resistant to infection

    IMMUNITY

  • 6

    the phenomenon in which exposure to one infectious agent produces protection against another agent

    CROSS IMMUNITY

  • 7

    Substance that stimulates antibody formation and has the ability to bind to an antibody

    ANTIGEN

  • 8

    Does not have the ability to induce immune response

    ANTIGEN

  • 9

    Any substance capable of inducing an immune response

    IMMUNOGEN

  • 10

    does not have the capability of inducing an immune response

    ANTIGEN

  • 11

    A substance specifically binds to antibodies or a cell surface receptors of B cells and T cells

    ANTIGEN

  • 12

    Normally proteins and large polysaccharides

    IMMUNOGEN

  • 13

    are large polysaccharides are considered the most powerful immunogens

    PROTEIN

  • 14

    are considered weak immunogens

    LIPID, NUCLEIC ACID

  • 15

    A low molecular weight, nonantigenic substance that, when combined with an antigen, changes the antigenic specificity of that antigen

    HAPTEN

  • 16

    The leaves of poison ivy contain

    PENTADECYLCATECHOL

  • 17

    A glycoprotein substance (immunoglobin) that is produced by B lymphocytes in response to an antigen

    ANTIBODY

  • 18

    where types of immunoglobulins differ from one another

    VARIABLE REGION

  • 19

    produced by the body’s immune system against “self” antigens

    AUTOANTIBODY

  • 20

    formed in response to antigens from individuals of the same species

    ALLOANTIBODY

  • 21

    part of an antigen that reacts specifically with an antibody or T-cell receptor

    EPITOPE

  • 22

    the clumping of particulate antigens by antibodies specific for the antigens.?

    AGGLUTINATION

  • 23

    the tendency that an epitope has for combining with the antigen-binding site on an antibody molecule. Strength of a single antibody-antigen interaction

    AFFINITY

  • 24

    strength of the bond between the antigen and the antibody. Strength of all interactions combined

    AVIDITY

  • 25

    smallest amount of antigen or antibody that can be detected.

    SENSITIVITY

  • 26

    ability of an antibody to bind to an antigen with complementary determinants and not to a antigen with dissimilar determinants.

    SPECIFICITY

  • 27

    a highly sensitive and specific test used in laboratories

    RADIOIMMUNOASSAY

  • 28

    group of proteins synthesized in mononuclear phagocytes, hepatocytes, fibroblasts, and some endothelial cells.

    COMPLEMENT

  • 29

    a small peptide formed during complement activation that causes increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils and mast cells.

    ANAPHYLATOXIN

  • 30

    a life-threatening response to an allergen characterized by the systematic release of histamine

    ANAPHYLAXIS

  • 31

    meaning “exempt,” is the source of the English word immunity, meaning the state of protection from infectious disease.

    IMMUNIS

  • 32

    mentioned that the great plaque that swept through Athens and how those who survived it, including himself, could tend to the sick without worrying about catching it again.

    THUCYDIDES

  • 33

    Chinese developed a practice of inhaling powder made from smallpox scabs in order to produce protection against this dreaded disease. • If a healthy individual was exposed as a child or young adult, the effects of the disease will be minimized.

    VARIOLATION

  • 34

    practice of deliberately exposing an individual to material from smallpox lesions.?

    VARIOLATION

  • 35

    discovered a remarkable relationship between exposure to cowpox and immunity to smallpox.

    EDWARD JENNER

  • 36

    the Latin word for “cow”) - procedure of injecting cellular material.

    VACCINATION

  • 37

    to make a pathogen less virulent through heat, aging or chemical means.

    ATTENUATION

  • 38

    Discovered Antihistamines

    DANIEL BOVET

  • 39

    He made an experiment, wherein he collected the spinal cords of the patients that died because of rabies. He dried the spinal cords and injected it to his patients. After 12 injections, the patients were protected against rabies.

    LOUIS PASTEUR

  • 40

    identified Anthrax and created the Koch's postulate

    ROBERT KOCH

  • 41

    proposed the antibody formation theory and developed a series of tissue staining dyes including …purple bacillus

    PAUL EHRLICH

  • 42

    proposed the cellular theory of immunity, cell-eating and phagocytosis

    ELLIE METCHNIKOFF

  • 43

    the most common Ig used for creating reagent antibody.

    lgG

  • 44

    It is the predominant immunoglobulin in secretions such as tears, saliva, sweat, breast milk, and respiratory tract, genital, and intestinal secretions

    lgA

  • 45

    exists as a monomer, and its function is unknown.

    lgD

  • 46

    binds to crystallizable fragment (Fc) receptors on mast cells and basophils and is elevated during parasitic infections and Type I allergic reaction

    lgE

  • 47

    is the predominant immunoglobulin in the adult. s. It is also the only immunoglobulin that crosses the placental barrier, thus transferring immunity from mother to infant.

    lgG

  • 48

    is the largest of the immunoglobulins, existing as a pentamer. It is the first immunoglobulin to be produced after exposure to an antigen

    lgM

  • 49

    Father of Immunology.

    LOUIS PASTEUR

  • 50

    Phagocytosis

    HAECKEL

  • 51

    Live, attenuated chicken cholera and anthrax vaccines

    LOUIS PASTEUR

  • 52

    Therapeutic vaccination; First report of live "attenuated" vaccine for rabies

    LOUIS PASTEUR

  • 53

    Humoral theory of immunity proposed

    VON BEHRING KITASATA

  • 54

    Demonstration of cutaneous hypersensitivity

    ROBERT KOCH

  • 55

    Development of polio vaccine

    SALK, SABIN

  • 56

    Hypothesis of antigen- antibody binding

    MARRACK

  • 57

    Produced as different classes of immunoglobulins by many B-cell clones in response to an antigen

    POLYCLONAL ANTIBODY

  • 58

    Antibodies produced in response to antigens from another species

    HETEROANTIBODY

  • COMPH Lesson 5

    COMPH Lesson 5

    Jef Marc Valencia · 73問 · 2年前

    COMPH Lesson 5

    COMPH Lesson 5

    73問 • 2年前
    Jef Marc Valencia

    Discussion 1

    Discussion 1

    Jef Marc Valencia · 42問 · 2年前

    Discussion 1

    Discussion 1

    42問 • 2年前
    Jef Marc Valencia

    Dis 1

    Dis 1

    Jef Marc Valencia · 42問 · 2年前

    Dis 1

    Dis 1

    42問 • 2年前
    Jef Marc Valencia

    Shift -Systematic Error

    Shift -Systematic Error

    Jef Marc Valencia · 11問 · 2年前

    Shift -Systematic Error

    Shift -Systematic Error

    11問 • 2年前
    Jef Marc Valencia

    LEVEY – JENNINGS CHART

    LEVEY – JENNINGS CHART

    Jef Marc Valencia · 8問 · 2年前

    LEVEY – JENNINGS CHART

    LEVEY – JENNINGS CHART

    8問 • 2年前
    Jef Marc Valencia

    WESTGARD MULTIRULE CHART

    WESTGARD MULTIRULE CHART

    Jef Marc Valencia · 6問 · 2年前

    WESTGARD MULTIRULE CHART

    WESTGARD MULTIRULE CHART

    6問 • 2年前
    Jef Marc Valencia

    Random vs Systematic

    Random vs Systematic

    Jef Marc Valencia · 5問 · 2年前

    Random vs Systematic

    Random vs Systematic

    5問 • 2年前
    Jef Marc Valencia

    Researcj Design

    Researcj Design

    Jef Marc Valencia · 48問 · 2年前

    Researcj Design

    Researcj Design

    48問 • 2年前
    Jef Marc Valencia

    Dis 1 mid

    Dis 1 mid

    Jef Marc Valencia · 40問 · 2年前

    Dis 1 mid

    Dis 1 mid

    40問 • 2年前
    Jef Marc Valencia

    COMPM LESSON 6-7

    COMPM LESSON 6-7

    Jef Marc Valencia · 63問 · 2年前

    COMPM LESSON 6-7

    COMPM LESSON 6-7

    63問 • 2年前
    Jef Marc Valencia

    Discussion -2 Six Sigma

    Discussion -2 Six Sigma

    Jef Marc Valencia · 31問 · 2年前

    Discussion -2 Six Sigma

    Discussion -2 Six Sigma

    31問 • 2年前
    Jef Marc Valencia

    Sigma Levels

    Sigma Levels

    Jef Marc Valencia · 6問 · 2年前

    Sigma Levels

    Sigma Levels

    6問 • 2年前
    Jef Marc Valencia

    COMPH- LESSON 8

    COMPH- LESSON 8

    Jef Marc Valencia · 46問 · 2年前

    COMPH- LESSON 8

    COMPH- LESSON 8

    46問 • 2年前
    Jef Marc Valencia

    Long Discussion ANALYTICAL METHODS & INSTRUMENTATION

    Long Discussion ANALYTICAL METHODS & INSTRUMENTATION

    Jef Marc Valencia · 81問 · 2年前

    Long Discussion ANALYTICAL METHODS & INSTRUMENTATION

    Long Discussion ANALYTICAL METHODS & INSTRUMENTATION

    81問 • 2年前
    Jef Marc Valencia

    WAVELENGTH Color Table

    WAVELENGTH Color Table

    Jef Marc Valencia · 9問 · 2年前

    WAVELENGTH Color Table

    WAVELENGTH Color Table

    9問 • 2年前
    Jef Marc Valencia

    Quiz Announcement ANALYTICAL METHODS & INSTRUMENTATION

    Quiz Announcement ANALYTICAL METHODS & INSTRUMENTATION

    Jef Marc Valencia · 100問 · 2年前

    Quiz Announcement ANALYTICAL METHODS & INSTRUMENTATION

    Quiz Announcement ANALYTICAL METHODS & INSTRUMENTATION

    100問 • 2年前
    Jef Marc Valencia

    QUIz ANNOUNCEMENT part 2

    QUIz ANNOUNCEMENT part 2

    Jef Marc Valencia · 18問 · 2年前

    QUIz ANNOUNCEMENT part 2

    QUIz ANNOUNCEMENT part 2

    18問 • 2年前
    Jef Marc Valencia

    Electrochem

    Electrochem

    Jef Marc Valencia · 62問 · 2年前

    Electrochem

    Electrochem

    62問 • 2年前
    Jef Marc Valencia

    ELEC TROCH

    ELEC TROCH

    Jef Marc Valencia · 18問 · 1年前

    ELEC TROCH

    ELEC TROCH

    18問 • 1年前
    Jef Marc Valencia

    TRANSCRIPTION

    TRANSCRIPTION

    Jef Marc Valencia · 49問 · 1年前

    TRANSCRIPTION

    TRANSCRIPTION

    49問 • 1年前
    Jef Marc Valencia

    LIS

    LIS

    Jef Marc Valencia · 28問 · 1年前

    LIS

    LIS

    28問 • 1年前
    Jef Marc Valencia

    Carbohydrates

    Carbohydrates

    Jef Marc Valencia · 16問 · 1年前

    Carbohydrates

    Carbohydrates

    16問 • 1年前
    Jef Marc Valencia

    DIFFERENT PATHWAYS IN GLUCOSE METABOLISM

    DIFFERENT PATHWAYS IN GLUCOSE METABOLISM

    Jef Marc Valencia · 6問 · 1年前

    DIFFERENT PATHWAYS IN GLUCOSE METABOLISM

    DIFFERENT PATHWAYS IN GLUCOSE METABOLISM

    6問 • 1年前
    Jef Marc Valencia

    III. GLUCOSE MEASUREMENT

    III. GLUCOSE MEASUREMENT

    Jef Marc Valencia · 6問 · 1年前

    III. GLUCOSE MEASUREMENT

    III. GLUCOSE MEASUREMENT

    6問 • 1年前
    Jef Marc Valencia

    Copper Reductions

    Copper Reductions

    Jef Marc Valencia · 7問 · 1年前

    Copper Reductions

    Copper Reductions

    7問 • 1年前
    Jef Marc Valencia

    Exp.8

    Exp.8

    Jef Marc Valencia · 29問 · 1年前

    Exp.8

    Exp.8

    29問 • 1年前
    Jef Marc Valencia

    QUIZ 8/9

    QUIZ 8/9

    Jef Marc Valencia · 29問 · 1年前

    QUIZ 8/9

    QUIZ 8/9

    29問 • 1年前
    Jef Marc Valencia

    Immunology

    Immunology

    Jef Marc Valencia · 29問 · 1年前

    Immunology

    Immunology

    29問 • 1年前
    Jef Marc Valencia

    Immunology part 2

    Immunology part 2

    Jef Marc Valencia · 22問 · 1年前

    Immunology part 2

    Immunology part 2

    22問 • 1年前
    Jef Marc Valencia

    Immunology 3

    Immunology 3

    Jef Marc Valencia · 8問 · 1年前

    Immunology 3

    Immunology 3

    8問 • 1年前
    Jef Marc Valencia

    Lesson 4

    Lesson 4

    Jef Marc Valencia · 6問 · 1年前

    Lesson 4

    Lesson 4

    6問 • 1年前
    Jef Marc Valencia

    PROTEINS

    PROTEINS

    Jef Marc Valencia · 26問 · 1年前

    PROTEINS

    PROTEINS

    26問 • 1年前
    Jef Marc Valencia

    PROTEIN 2

    PROTEIN 2

    Jef Marc Valencia · 34問 · 1年前

    PROTEIN 2

    PROTEIN 2

    34問 • 1年前
    Jef Marc Valencia

    PROTEIN 3

    PROTEIN 3

    Jef Marc Valencia · 29問 · 1年前

    PROTEIN 3

    PROTEIN 3

    29問 • 1年前
    Jef Marc Valencia

    Serum Albumin Determination

    Serum Albumin Determination

    Jef Marc Valencia · 56問 · 1年前

    Serum Albumin Determination

    Serum Albumin Determination

    56問 • 1年前
    Jef Marc Valencia

    CC lec debris

    CC lec debris

    Jef Marc Valencia · 14問 · 1年前

    CC lec debris

    CC lec debris

    14問 • 1年前
    Jef Marc Valencia

    NPN

    NPN

    Jef Marc Valencia · 44問 · 1年前

    NPN

    NPN

    44問 • 1年前
    Jef Marc Valencia

    NPN 2

    NPN 2

    Jef Marc Valencia · 29問 · 1年前

    NPN 2

    NPN 2

    29問 • 1年前
    Jef Marc Valencia

    Materials management

    Materials management

    Jef Marc Valencia · 33問 · 1年前

    Materials management

    Materials management

    33問 • 1年前
    Jef Marc Valencia

    Liver

    Liver

    Jef Marc Valencia · 57問 · 1年前

    Liver

    Liver

    57問 • 1年前
    Jef Marc Valencia

    LESSON 10

    LESSON 10

    Jef Marc Valencia · 29問 · 1年前

    LESSON 10

    LESSON 10

    29問 • 1年前
    Jef Marc Valencia

    hyperlipoproteinemia

    hyperlipoproteinemia

    Jef Marc Valencia · 25問 · 1年前

    hyperlipoproteinemia

    hyperlipoproteinemia

    25問 • 1年前
    Jef Marc Valencia

    CM

    CM

    Jef Marc Valencia · 8問 · 1年前

    CM

    CM

    8問 • 1年前
    Jef Marc Valencia

    OBLIGATE INTRACELLULAR BACTERIA

    OBLIGATE INTRACELLULAR BACTERIA

    Jef Marc Valencia · 24問 · 1年前

    OBLIGATE INTRACELLULAR BACTERIA

    OBLIGATE INTRACELLULAR BACTERIA

    24問 • 1年前
    Jef Marc Valencia

    THE SPIROCHETES

    THE SPIROCHETES

    Jef Marc Valencia · 48問 · 1年前

    THE SPIROCHETES

    THE SPIROCHETES

    48問 • 1年前
    Jef Marc Valencia

    PYOGENIC GRAM POSTIVE

    PYOGENIC GRAM POSTIVE

    Jef Marc Valencia · 31問 · 1年前

    PYOGENIC GRAM POSTIVE

    PYOGENIC GRAM POSTIVE

    31問 • 1年前
    Jef Marc Valencia

    Introduction

    Introduction

    Jef Marc Valencia · 31問 · 1年前

    Introduction

    Introduction

    31問 • 1年前
    Jef Marc Valencia

    Introduction Page 2

    Introduction Page 2

    Jef Marc Valencia · 28問 · 1年前

    Introduction Page 2

    Introduction Page 2

    28問 • 1年前
    Jef Marc Valencia

    Introduction pg 3

    Introduction pg 3

    Jef Marc Valencia · 31問 · 1年前

    Introduction pg 3

    Introduction pg 3

    31問 • 1年前
    Jef Marc Valencia

    Introduction table

    Introduction table

    Jef Marc Valencia · 32問 · 1年前

    Introduction table

    Introduction table

    32問 • 1年前
    Jef Marc Valencia

    Introduction-body

    Introduction-body

    Jef Marc Valencia · 14問 · 1年前

    Introduction-body

    Introduction-body

    14問 • 1年前
    Jef Marc Valencia

    NK-Immunity

    NK-Immunity

    Jef Marc Valencia · 28問 · 1年前

    NK-Immunity

    NK-Immunity

    28問 • 1年前
    Jef Marc Valencia

    meet 2

    meet 2

    Jef Marc Valencia · 45問 · 1年前

    meet 2

    meet 2

    45問 • 1年前
    Jef Marc Valencia

    discussion 3

    discussion 3

    Jef Marc Valencia · 38問 · 1年前

    discussion 3

    discussion 3

    38問 • 1年前
    Jef Marc Valencia

    dis 1

    dis 1

    Jef Marc Valencia · 25問 · 1年前

    dis 1

    dis 1

    25問 • 1年前
    Jef Marc Valencia

    Immuno vs anti

    Immuno vs anti

    Jef Marc Valencia · 29問 · 1年前

    Immuno vs anti

    Immuno vs anti

    29問 • 1年前
    Jef Marc Valencia

    Immune 3

    Immune 3

    Jef Marc Valencia · 47問 · 1年前

    Immune 3

    Immune 3

    47問 • 1年前
    Jef Marc Valencia

    dis 4

    dis 4

    Jef Marc Valencia · 46問 · 1年前

    dis 4

    dis 4

    46問 • 1年前
    Jef Marc Valencia

    TRANSUDATIVE Vs. EXUDATIVE

    TRANSUDATIVE Vs. EXUDATIVE

    Jef Marc Valencia · 12問 · 1年前

    TRANSUDATIVE Vs. EXUDATIVE

    TRANSUDATIVE Vs. EXUDATIVE

    12問 • 1年前
    Jef Marc Valencia

    dis 5

    dis 5

    Jef Marc Valencia · 75問 · 1年前

    dis 5

    dis 5

    75問 • 1年前
    Jef Marc Valencia

    Preserved Tissue Examination Steps by definition

    Preserved Tissue Examination Steps by definition

    Jef Marc Valencia · 9問 · 1年前

    Preserved Tissue Examination Steps by definition

    Preserved Tissue Examination Steps by definition

    9問 • 1年前
    Jef Marc Valencia

    FIXATIVES

    FIXATIVES

    Jef Marc Valencia · 28問 · 1年前

    FIXATIVES

    FIXATIVES

    28問 • 1年前
    Jef Marc Valencia

    Long discussion 1

    Long discussion 1

    Jef Marc Valencia · 70問 · 1年前

    Long discussion 1

    Long discussion 1

    70問 • 1年前
    Jef Marc Valencia

    ALDEHYDE-FIXATIVES

    ALDEHYDE-FIXATIVES

    Jef Marc Valencia · 10問 · 1年前

    ALDEHYDE-FIXATIVES

    ALDEHYDE-FIXATIVES

    10問 • 1年前
    Jef Marc Valencia

    lactate dehydrogenase

    lactate dehydrogenase

    Jef Marc Valencia · 24問 · 1年前

    lactate dehydrogenase

    lactate dehydrogenase

    24問 • 1年前
    Jef Marc Valencia

    FIXATIVES-METALLIC

    FIXATIVES-METALLIC

    Jef Marc Valencia · 6問 · 1年前

    FIXATIVES-METALLIC

    FIXATIVES-METALLIC

    6問 • 1年前
    Jef Marc Valencia

    FIXATIVES-CHROMATE

    FIXATIVES-CHROMATE

    Jef Marc Valencia · 5問 · 1年前

    FIXATIVES-CHROMATE

    FIXATIVES-CHROMATE

    5問 • 1年前
    Jef Marc Valencia

    Specialized Macrophages

    Specialized Macrophages

    Jef Marc Valencia · 10問 · 1年前

    Specialized Macrophages

    Specialized Macrophages

    10問 • 1年前
    Jef Marc Valencia

    LYMPHOPOIESIS

    LYMPHOPOIESIS

    Jef Marc Valencia · 14問 · 1年前

    LYMPHOPOIESIS

    LYMPHOPOIESIS

    14問 • 1年前
    Jef Marc Valencia

    PICRIC ACID-FIXATIVE

    PICRIC ACID-FIXATIVE

    Jef Marc Valencia · 5問 · 1年前

    PICRIC ACID-FIXATIVE

    PICRIC ACID-FIXATIVE

    5問 • 1年前
    Jef Marc Valencia

    immune 4

    immune 4

    Jef Marc Valencia · 33問 · 1年前

    immune 4

    immune 4

    33問 • 1年前
    Jef Marc Valencia

    FIXATIVES-ALCOHOL

    FIXATIVES-ALCOHOL

    Jef Marc Valencia · 8問 · 1年前

    FIXATIVES-ALCOHOL

    FIXATIVES-ALCOHOL

    8問 • 1年前
    Jef Marc Valencia

    Immunoglobulins

    Immunoglobulins

    Jef Marc Valencia · 40問 · 1年前

    Immunoglobulins

    Immunoglobulins

    40問 • 1年前
    Jef Marc Valencia

    ARTIFACTS

    ARTIFACTS

    Jef Marc Valencia · 6問 · 1年前

    ARTIFACTS

    ARTIFACTS

    6問 • 1年前
    Jef Marc Valencia

    FIXATIVES QUIZ COPY

    FIXATIVES QUIZ COPY

    Jef Marc Valencia · 11問 · 1年前

    FIXATIVES QUIZ COPY

    FIXATIVES QUIZ COPY

    11問 • 1年前
    Jef Marc Valencia

    MAJOR HISTOCOMPATIBILITY

    MAJOR HISTOCOMPATIBILITY

    Jef Marc Valencia · 26問 · 1年前

    MAJOR HISTOCOMPATIBILITY

    MAJOR HISTOCOMPATIBILITY

    26問 • 1年前
    Jef Marc Valencia

    OTHERS-FIXATIVES

    OTHERS-FIXATIVES

    Jef Marc Valencia · 5問 · 1年前

    OTHERS-FIXATIVES

    OTHERS-FIXATIVES

    5問 • 1年前
    Jef Marc Valencia

    MEGAKARYOPOLESIS

    MEGAKARYOPOLESIS

    Jef Marc Valencia · 34問 · 1年前

    MEGAKARYOPOLESIS

    MEGAKARYOPOLESIS

    34問 • 1年前
    Jef Marc Valencia

    DECALCIFICATION

    DECALCIFICATION

    Jef Marc Valencia · 51問 · 1年前

    DECALCIFICATION

    DECALCIFICATION

    51問 • 1年前
    Jef Marc Valencia

    DEHYDRATION

    DEHYDRATION

    Jef Marc Valencia · 64問 · 1年前

    DEHYDRATION

    DEHYDRATION

    64問 • 1年前
    Jef Marc Valencia

    Blood Specimen Collection

    Blood Specimen Collection

    Jef Marc Valencia · 8問 · 1年前

    Blood Specimen Collection

    Blood Specimen Collection

    8問 • 1年前
    Jef Marc Valencia

    CLEARING

    CLEARING

    Jef Marc Valencia · 7問 · 1年前

    CLEARING

    CLEARING

    7問 • 1年前
    Jef Marc Valencia

    CEARING AGENT

    CEARING AGENT

    Jef Marc Valencia · 19問 · 1年前

    CEARING AGENT

    CEARING AGENT

    19問 • 1年前
    Jef Marc Valencia

    INTRODUCTION

    INTRODUCTION

    Jef Marc Valencia · 27問 · 1年前

    INTRODUCTION

    INTRODUCTION

    27問 • 1年前
    Jef Marc Valencia

    Introduction

    Introduction

    Jef Marc Valencia · 51問 · 1年前

    Introduction

    Introduction

    51問 • 1年前
    Jef Marc Valencia

    Methods of Determination

    Methods of Determination

    Jef Marc Valencia · 12問 · 1年前

    Methods of Determination

    Methods of Determination

    12問 • 1年前
    Jef Marc Valencia

    ASPARTATE AMINOTRANSFERASE

    ASPARTATE AMINOTRANSFERASE

    Jef Marc Valencia · 11問 · 1年前

    ASPARTATE AMINOTRANSFERASE

    ASPARTATE AMINOTRANSFERASE

    11問 • 1年前
    Jef Marc Valencia

    ALANINE AMINOTRANSFERASE

    ALANINE AMINOTRANSFERASE

    Jef Marc Valencia · 15問 · 1年前

    ALANINE AMINOTRANSFERASE

    ALANINE AMINOTRANSFERASE

    15問 • 1年前
    Jef Marc Valencia

    Creatinine Kinase

    Creatinine Kinase

    Jef Marc Valencia · 34問 · 1年前

    Creatinine Kinase

    Creatinine Kinase

    34問 • 1年前
    Jef Marc Valencia

    LACTATE DEHYDROGENASE

    LACTATE DEHYDROGENASE

    Jef Marc Valencia · 27問 · 1年前

    LACTATE DEHYDROGENASE

    LACTATE DEHYDROGENASE

    27問 • 1年前
    Jef Marc Valencia

    ACID PHOSPHATASE

    ACID PHOSPHATASE

    Jef Marc Valencia · 41問 · 1年前

    ACID PHOSPHATASE

    ACID PHOSPHATASE

    41問 • 1年前
    Jef Marc Valencia

    問題一覧

  • 1

    The study of the molecules, cells, organs, and systems responsible for the recognition and disposal of foreign (nonself) materials

    IMMUNOLOGY

  • 2

    Considered as foreign substances a.k.a Antigens

    NONSELF

  • 3

    The body can’t discriminate self from non-self.

    AUTOIMMUNE DISEASE

  • 4

    Diagnostic examination of blood serum and other body fluids with regards to the response of the immune system to pathogens.

    SEROLOGY

  • 5

    Condition of being resistant to infection

    IMMUNITY

  • 6

    the phenomenon in which exposure to one infectious agent produces protection against another agent

    CROSS IMMUNITY

  • 7

    Substance that stimulates antibody formation and has the ability to bind to an antibody

    ANTIGEN

  • 8

    Does not have the ability to induce immune response

    ANTIGEN

  • 9

    Any substance capable of inducing an immune response

    IMMUNOGEN

  • 10

    does not have the capability of inducing an immune response

    ANTIGEN

  • 11

    A substance specifically binds to antibodies or a cell surface receptors of B cells and T cells

    ANTIGEN

  • 12

    Normally proteins and large polysaccharides

    IMMUNOGEN

  • 13

    are large polysaccharides are considered the most powerful immunogens

    PROTEIN

  • 14

    are considered weak immunogens

    LIPID, NUCLEIC ACID

  • 15

    A low molecular weight, nonantigenic substance that, when combined with an antigen, changes the antigenic specificity of that antigen

    HAPTEN

  • 16

    The leaves of poison ivy contain

    PENTADECYLCATECHOL

  • 17

    A glycoprotein substance (immunoglobin) that is produced by B lymphocytes in response to an antigen

    ANTIBODY

  • 18

    where types of immunoglobulins differ from one another

    VARIABLE REGION

  • 19

    produced by the body’s immune system against “self” antigens

    AUTOANTIBODY

  • 20

    formed in response to antigens from individuals of the same species

    ALLOANTIBODY

  • 21

    part of an antigen that reacts specifically with an antibody or T-cell receptor

    EPITOPE

  • 22

    the clumping of particulate antigens by antibodies specific for the antigens.?

    AGGLUTINATION

  • 23

    the tendency that an epitope has for combining with the antigen-binding site on an antibody molecule. Strength of a single antibody-antigen interaction

    AFFINITY

  • 24

    strength of the bond between the antigen and the antibody. Strength of all interactions combined

    AVIDITY

  • 25

    smallest amount of antigen or antibody that can be detected.

    SENSITIVITY

  • 26

    ability of an antibody to bind to an antigen with complementary determinants and not to a antigen with dissimilar determinants.

    SPECIFICITY

  • 27

    a highly sensitive and specific test used in laboratories

    RADIOIMMUNOASSAY

  • 28

    group of proteins synthesized in mononuclear phagocytes, hepatocytes, fibroblasts, and some endothelial cells.

    COMPLEMENT

  • 29

    a small peptide formed during complement activation that causes increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils and mast cells.

    ANAPHYLATOXIN

  • 30

    a life-threatening response to an allergen characterized by the systematic release of histamine

    ANAPHYLAXIS

  • 31

    meaning “exempt,” is the source of the English word immunity, meaning the state of protection from infectious disease.

    IMMUNIS

  • 32

    mentioned that the great plaque that swept through Athens and how those who survived it, including himself, could tend to the sick without worrying about catching it again.

    THUCYDIDES

  • 33

    Chinese developed a practice of inhaling powder made from smallpox scabs in order to produce protection against this dreaded disease. • If a healthy individual was exposed as a child or young adult, the effects of the disease will be minimized.

    VARIOLATION

  • 34

    practice of deliberately exposing an individual to material from smallpox lesions.?

    VARIOLATION

  • 35

    discovered a remarkable relationship between exposure to cowpox and immunity to smallpox.

    EDWARD JENNER

  • 36

    the Latin word for “cow”) - procedure of injecting cellular material.

    VACCINATION

  • 37

    to make a pathogen less virulent through heat, aging or chemical means.

    ATTENUATION

  • 38

    Discovered Antihistamines

    DANIEL BOVET

  • 39

    He made an experiment, wherein he collected the spinal cords of the patients that died because of rabies. He dried the spinal cords and injected it to his patients. After 12 injections, the patients were protected against rabies.

    LOUIS PASTEUR

  • 40

    identified Anthrax and created the Koch's postulate

    ROBERT KOCH

  • 41

    proposed the antibody formation theory and developed a series of tissue staining dyes including …purple bacillus

    PAUL EHRLICH

  • 42

    proposed the cellular theory of immunity, cell-eating and phagocytosis

    ELLIE METCHNIKOFF

  • 43

    the most common Ig used for creating reagent antibody.

    lgG

  • 44

    It is the predominant immunoglobulin in secretions such as tears, saliva, sweat, breast milk, and respiratory tract, genital, and intestinal secretions

    lgA

  • 45

    exists as a monomer, and its function is unknown.

    lgD

  • 46

    binds to crystallizable fragment (Fc) receptors on mast cells and basophils and is elevated during parasitic infections and Type I allergic reaction

    lgE

  • 47

    is the predominant immunoglobulin in the adult. s. It is also the only immunoglobulin that crosses the placental barrier, thus transferring immunity from mother to infant.

    lgG

  • 48

    is the largest of the immunoglobulins, existing as a pentamer. It is the first immunoglobulin to be produced after exposure to an antigen

    lgM

  • 49

    Father of Immunology.

    LOUIS PASTEUR

  • 50

    Phagocytosis

    HAECKEL

  • 51

    Live, attenuated chicken cholera and anthrax vaccines

    LOUIS PASTEUR

  • 52

    Therapeutic vaccination; First report of live "attenuated" vaccine for rabies

    LOUIS PASTEUR

  • 53

    Humoral theory of immunity proposed

    VON BEHRING KITASATA

  • 54

    Demonstration of cutaneous hypersensitivity

    ROBERT KOCH

  • 55

    Development of polio vaccine

    SALK, SABIN

  • 56

    Hypothesis of antigen- antibody binding

    MARRACK

  • 57

    Produced as different classes of immunoglobulins by many B-cell clones in response to an antigen

    POLYCLONAL ANTIBODY

  • 58

    Antibodies produced in response to antigens from another species

    HETEROANTIBODY